A new PEARLS article in PLoS Pathogens reviews the rapid evolution and pandemic potential of emerging influenza A viruses, with a focus on H5N1. It highlights scientific advances and future strategies to outpace the virus,

Pediatric patients exhibited high risk for severe avian influenza A/H5N1, suggesting clinical therapeutic and vaccine trials should be prioritized in this population.

CC-42344 was shown to be highly active against the highly pathogenic 2024 Texas H5N1 avian influenza strain <li /> The Company's virolo

Highly pathogenic avian influenza viruses like H5N1, H5N6, and H7N9 pose an evolving global threat due to their capacity to infect birds, mammals, and occasionally humans, with sporadic outbreaks and limited treatment options.

Brazil has reported its first H5N1 avian flu outbreak in commercial poultry, which began on May 12 near the city of Montenegro in Rio Grande do Sul, the country’s southernmost state, according to a notification today from the World Organization for Animal Health.

This was in addition to $176 million awarded by the U.S. Department of Health and Human Services last year to complete the late-stage development and testing of a pre-pandemic mRNA-based vaccine against the H5N1 avian influenza. Moderna said it plans to explore alternatives for late-stage development and manufacturing of the vaccine.